AstraZeneca and Merck Rapidly Advance LYNPARZA in Japan With a Second Regulatory Submission
AstraZeneca and Merck , known as MSD outside the U.S. and Canada, announced that they have submitted a NDA to ...
Tag: Asia Pacific
Liquid Learning presents the Women in Pharma and Medical Leadership Summit 2017 to be held in Auckland on the 21st-23rd of March.
Liquid Learning is delighted to present the Women in Pharma and Medical Leadership Summit. A unique platform in New Zealand ...
Takeda Presents $1 Million Gift to the Koch Institute for Integrative Cancer Research
Takeda Pharma and the Koch Institute for Integrative Cancer Research at MIT jointly announced that Takeda will support groundbreaking science ...
TOT BIOPHARM and LEE’S PHARM Signed an Exclusive Licensing Agreement on Monoclonal Antibody Drug
TOT BIOPHARM Co Ltd. and LEE'S PHARMACEUTICAL HOLDINGS LIMITED jointly announced that LEE'S PHARM, through its wholly-owned subsidiary Zhaoke (Guangzhou) ...
WuXi Biologics completes construction of Asia’s largest perfusion biologics manufacturing facility using disposable bioreactors
WuXi Biologics, a leading open-access R&D capability and technology platform company dedicated to biologics and a WuXi AppTec company, announced ...
Pfizer Bolsters China Presence With $350 Million Plant
Pfizer Inc. will invest $350 million in eastern China on a plant for biotechnology drugs, bolstering its presence in the ...
Key exhibitors and industry partners show strong support for MEDICAL MANUFACTURING ASIA 2016
3rd Manufacturing Processes for Medical Technology Exhibition and Conference sets the stage as the industry’s knowledge-information exchange platform ...
NATCO Pharma Limited receives USFDA tentative approval for Sorafenib Tablets, 200mg
Natco Pharma Limited announced that its marketing partner, Mylan Inc has received a tentative approval for its Abbreviated New Drug ...
Astellas, Daiichi Sankyo, and Takeda Announce Research Collaboration on Establishing Biomarker Database on Healthy Adults
Three Pharmaceutical Companies with Research Bases in Japan Work Together to Accelerate Innovation in Japan-Originated Drug DiscoveryAstellas Pharma Inc , ...
Anti-Cancer Agent Avastin Obtained Approval for Additional Indication of Advanced or Recurrent Cervical Cancer
Chugai Pharmaceutical Co Ltd announced that it gained approval by the Japanese Ministry of Health, Labour and Welfare (MHLW) on ...
About Us
Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.